Colorado blames Biden team and drugmakers for delaying Canadian imports

Colorado officials say their plan to import cheaper medicines from Canada has been stymied by opposition from drugmakers and inaction by the Biden administration, according to a state report obtained by KFF Health News.

Risk Adjusted Net Present Value: What is the current valuation of CRISPR Therapeutics’s CTX-112

The revenue for CTX-112 is expected to reach an annual total of $65 mn by 2038 in the US based off GlobalData’s Expiry Model. The

July 2, 2024

Opinion | ‘Can Certainly Happen in Patients Who Are Not Surfers’: What We Heard This Week

“It can certainly happen in patients who are not surfers.” — Matthew Gorski, MD, of Northwell Health in Great Neck, New York, on the risk

August 26, 2024

Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch

What You Should Know: – Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.